Dan T. Vogl - Concepedia

Author

Dan T. Vogl

University of Pennsylvania ORCID

Also Known As

Campbell, Matthew, D T Vogl, D Vogl, D. T. Vogl, D. Vogl, D.T. Vogl, Dan T Vogl, Dan T. Vogl, Dan Vogl, Daniel Vogl

359

Publications

17.8K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Hackensack University Medical Center Medical College of Wisconsin Dana-Farber Cancer Institute The University of Texas MD Anderson Cancer Center

About

Dan T. Vogl is an author at University of Pennsylvania specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	33	4.3K
2	Health Sciences	10	10	540
3	Public Health	2	2	227
4	Allergy	2	2	128
5	Business	1	1	211

Dan T. Vogl

108

Publications

16.6K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe, Autophagy	2016	5.9K
NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl, Nature Medicine Cancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint InhibitorAntigen-specific Antitumor Effects	2015	832
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients Thomas Condamine, George A. Dominguez, Je‐In Youn, Science Immunology	2016	777
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma Adam D. Cohen, Alfred L. Garfall, Edward A. Stadtmauer, Journal of Clinical Investigation	2019	768
Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, New England Journal of Medicine	2019	655
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma Alfred L. Garfall, Marcela V. Maus, Wei‐Ting Hwang, New England Journal of Medicine Cell TherapyImmunologyPathologyAutologous TransplantationCd4 T Cell Responses	2015	614
Combined autophagy and proteasome inhibition Dan T. Vogl, Edward A. Stadtmauer, Kay-See Tan, Autophagy MitophagyImmunologyProteasomeCell DeathPharmacotherapy	2014	365
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial Amrita Krishnan, Marcelo C. Pasquini, Brent R. Logan, The Lancet Oncology Hematological MalignancyCell TherapyTransplantationMarrow TransplantationStem Cell Transplantation	2011	277
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial Edward A. Stadtmauer, Marcelo C. Pasquini, Beth Blackwell, Journal of Clinical Oncology	2019	256
Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma Dan T. Vogl, Noopur Raje, Sundar Jagannath, Clinical Cancer Research	2017	246

Page 1